GlassScriptPhysician profile
Wanzhi Li
NPI 1326660713
$685.80
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.09 · 2021: $161 · 2022: $58.88 · 2023: $20.41 · 2024: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $169.51 | 2021-2024 | |
| Coopervision INC. | $166.63 | 2020-2023 | Paragon Crt |
| Tarsus Pharmaceuticals, INC. | $134.74 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $38.52 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $38.39 | 2024 | Clarus |
| Dompe US, INC. | $32.05 | 2024 | Oxervate |
| Abbvie INC. | $24.25 | 2024 | |
| Bausch & Lomb Americas INC. | $23.65 | 2024 | Xiidra, Miebo |
| Novartis Pharmaceuticals Corporation | $20.80 | 2022 | |
| Alcon Vision LLC | $20.02 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanzhi Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.